学術雑誌掲載論文

• Nakayama S, Iwamoto T, Araki K, Narui K, Nakayama T, Nagase H, Sugimoto N,
  Taira N, Aihara T, Kikawa Y, Mukai H. A prospective cohort study of abemaciclib-induced interstitial lung disease in metastatic breast cancer after chemotherapy. Breast cancer, 2025 May;32(3):607-612.
• Jo A, Iwamoto T, Suzuki Y, Ogata R, Koike Y, Nomura T, Tanaka K, Miyoshi Y,
  Hara K, Yoshitomi S, Hikino H, Takahashi H, Takabatake D, Kubo S, Ikeda M, Shien
  T, Doihara H, Kikawa Y, Taira N. Validation of the Symptom Illustration Scale within an electronic Patient-Reported Outcomes Monitoring environment for metastatic breast cancer patients undergoing chemotherapy.Breast cancer. 2025 Jul;32(4):783-791.
• Matsubara Y, Suganuma N, Nakamoto S, Kikawa Y, Iwamoto T, Yamanaka T, Yoshida
  T, Yamashita T, Saitou A. Repeated sentinel lymph node biopsy for local recurrence after breast-conserving surgery. Breast cancer. 2025 May;32(3):512-519.
• Taira N, Kiyota N, Kikawa Y, Ichihara E, Kato K, Kubota K, Tateishi R, Nakata
  A, Nakamura K, Narita Y, Hotta K, Iwata H, Gemma A, Shimozuma K, Muro K, Iwamoto
  T, Takumoto Y, Shiroiwa T, Fukuda T, Yamaguchi T, Hagiwara Y, Minami H. Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors. Jpn J Clin Oncol. 2025 Apr 26;55(5):547-555. 
• Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, Bottomley A, Cameron D, Brain E, Hartup S, Da Costa Vieira RA, Hoefnagels N, Huang CS, Shamieh O, Pinto M, Belay YB, Serpentini S, Bleiker E, Nookala M, Shimomura A, Sturm-Inwald E, Getu MA, Bliem B, Astrup G, Morag O, Kikawa Y, Kuljanic K, Nevries N, Sprangers M, Aaronson N, Sinai P, Tomaszweski K, Galalae R, Conroy T, Duhoux F, Chie WC, Velikova G; EORTC Quality of Life Group and Breast Cancer Group. An international Phase IV field study – psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42. Breast. 2025 Apr:80:103890. 
• Wakaki N, Shimoi T, Nakamoto S, Kikawa Y, Ito A, Iwamoto T. Double heterozygosity for BRCA1 and BRCA2 in breast cancer: considerations in surveillance and cancer risk management. BMJ Case Rep. 2025 Apr 22;18(4):e263687.
• Kuba S, Soutome S, Hagiwara Y, Kikawa Y, Iwamoto T, Sangai T, Harao M,Yamaguchi T, Taji T, Igarashi A, Kajimoto Y, Sakurai N, Yamanouchi K, Watanabe K, Maeda N, Suzuki M, Maeda S, Toh U, Ebata A, Iwakuma N, Matsunuma R, Yamaguchi M, Mukai H; CSPOR-BC. A randomized phase III study evaluating dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in patients with breast cancer. Jpn J Clin Oncol. 2025 Feb 4;55(2):172-175.
• Nakayama S, Yoshizawa A, Tsurutani J, Yoshimura K, Aoki G, Iwamoto T, Nagase H, Sugimoto N, Kobayashi K, Izumi S, Kato T, Miyazaki Y, Kurihara Y, Taira N, Aihara T, Kikawa Y, Mukai H.Real-world incidence of and risk factors for abemaciclib-induced interstitial lung disease in Japan: a nested case-control study of abemaciclib-induced interstitial lung disease (NOSIDE). Breast Cancer. 2025 Jan;32(1):177-185. 
•  Yoshinami T, Takano Y, Ozaki Y, Kajiwara Y, Yamamoto M, Watanabe KI, Tsukabe M, Fujisawa F, Nagai SE, Shibata N, Oshiro C, Bando H, Tsunoda N, Yamagami K, Koizumi K, Takada M, Toriguchi N, Sekine N, Kawaguchi T, Saji S, Sagara Y, Morita S, Masuda N. Real-world evidence from Japan regarding survival outcomes and treatment sequence in patients receiving CDK4/6 inhibitor plus endocrine therapy as first- or second-line treatment for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer. Breast Cancer. 2025 May 20. doi: 10.1007/s12282-025-01713-7. Epub ahead of print.
• Taguchi M, Takada M, Jiaxi H, Fukui Y, Shimizu H, Yamaguchi A, Kawaguchi K, Kawashima M, Kawaguchi-Sakita N, Toi M. Detection capability of the Medical Imaging Projection System for sentinel lymph node biopsy in patients with breast cancer with and without neoadjuvant chemotherapy: a retrospective study. Breast Cancer. 2025 May 10. doi: 10.1007/s12282-025-01712-8. Epub ahead of print.
• Nishimura T, Velaga R, Masuda N, Kawaguchi K, Kawaguchi S, Takada M, Maeshima Y, Tanaka S, Kikawa Y, Kadoya T, Bando H, Nakamura R, Yamamoto Y, Ueno T, Yasojima H, Ishiguro H, Morita S, Ohno S, Haga H, Matsuda F, Ogawa S, Toi M. Genomic and transcriptomic profiling of pre- and postneoadjuvant chemotherapy triple negative breast cancer tumors. Cancer Sci. 2024 Dec;115(12):3928-3942. doi: 10.1111/cas.16339.
• Iima M, Mizuno R, Kataoka M, Tsuji K, Yamazaki T, Minami A, Honda M, Imanishi K, Takada M, Nakamoto Y. Deep Learning Applied to Diffusion-weighted Imaging for Differentiating Malignant from Benign Breast Tumors without Lesion Segmentation. Radiol Artif Intell. 2024 Nov 20:e240206.
• Nishiyama T, Yamaguchi A, Han P, Pereira LWK, Otsuki Y, Andrade GHB, Kudo N, Yada S, Wakamiya S, Aramaki E, Takada M, Toi M. Automated System to Capture Patient Symptoms From Multitype Japanese Clinical Texts: Retrospective Study. JMIR Med Inform. 2024 Sep 24;12:e58977.
• Higami A, Takada M, Kawaguchi-Sakita N, Kawashima M, Kawaguchi K, Yamaguchi A, Takeuchi Y, Yamada Y, Toi M. Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of postmenopausal Japanese patients. Int J Clin Oncol. 2024 Nov;29(11):1715-1720. PMID: 39177880.
• Maeshima Y, Kataoka TR, Vandenbon A, Hirata M, Takeuchi Y, Suzuki Y, Fukui Y, Kawashima M, Takada M, Ibi Y, Haga H, Morita S, Toi M, Kawaoka S, Kawaguchi K. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals a reduction in CD169⁺ macrophages within metastatic breast cancers. EBioMedicine. 2024 Aug 21;107:105271. doi: 10.1016/j.ebiom.2024.105271. Epub ahead of print. PMID: 39173531.
• Kataoka M, Honda M, Sagawa H, Ohashi A, Sakaguchi R, Hashimoto H, Iima M, Takada M, Nakamoto Y. Ultrafast Dynamic Contrast-Enhanced MRI of the Breast: From Theory to Practice. J Magn Reson Imaging. 2024 Aug;60(2):401-416.
• Fujino M, Kawashima M, Yoshifuji H, Nakashima R, Yamada Y, Matsumoto Y, Kawaguchi-Sakita N, Mori Y, Pu F, Yamaguchi A, Kawaguchi K, Takada M, Toi M. Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery. Int Cancer Conf J. 2024 Jan 25;13(2):111-118.
• Toi M, Kinoshita T, Benson JR, Jatoi I, Kataoka M, Han W, Yamauchi C, Inamoto T, Takada M. Non-surgical ablation for breast cancer: an emerging therapeutic option. Lancet Oncol. 2024 Mar;25(3):e114-e125.
• Saldajeno DP, Kawaoka S, Masuda N, Tanaka S, Bando H, Nishimura T, Kadoya T, Yamanaka T, Imoto S, Velaga RM, Tamura N, Aruga T, Ikeda K, Fukui Y, Maeshima Y, Takada M, Suzuki E, Ueno T, Ogawa S, Haga H, Ohno S, Morita S, Kawaguchi K, Toi M. Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients. Br J Cancer. 2024 Apr;130(6):1023-1035.
• Yamaguchi A, Kawaguchi K, Kawanishi K, Maeshima Y, Nakakura A, Kataoka TR, Takahara S, Nakagawa S, Yonezawa A, Takada M, Kawashima M, Kawaguchi-Sakita N, Kotake T, Suzuki E, Shimizu H, Torii M, Morita S, Ishiguro H, Toi M. Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis. Breast Cancer Res Treat. 2024 Apr;204(2):261-275.
• Iwamoto T, Niikura N, Watanabe K, Takeshita T, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Kobayashi T, Katagiri Y, Kitada M, Tomioka N, Miyoshi Y, Shigematsu H, Miyashita M, Ishiguro H, Masuda N, Saji S. Prognostic value of the 21-Gene Breast Recurrence Score® assay for hormone receptor-positive/human epidermal growth factor 2-negative advanced breast cancer: subanalysis from Japan Breast Cancer Research Group-M07 (FUTURE trial) Breast Cancer Res Treat. 2024 Nov;208(2):253-262. 
• Tse SSW, Wong C, Tane K, Kikawa Y, Rafn BS, Chan AW, Lee SF, Kwan JYY, AlKhaifi M, Sheung R, Kwong C, Tse A, Sham K, Ling J, Liu YM, Leung C, Chan F, Tsang S, Wong J, Choy WY, Choy YP, Lai J, Shum T, Chow E, Wong HCY. Prospective surveillance and early intervention to prevent chronic breast cancer-related arm lymphedema-what are the barriers? Ann Palliat Med. 2024 Nov;13(6):1513-1520. 
• Rajeswaran T, Gojsevic M, Chan AW, Wong HCY, Lee SF, Bernard R, Marta GN,Pogoda K, Kwan JYY, Kuszaj O, Day M, Behroozian T, Bleiker EMA, Wong C, Kikawa Y, Tane K, Velikova G, Marcou Y, Bjelic-Radisic V, Karam I, Al-haifi M, Kennedy SKF, Chow E. Quality of life issues in patients with ductal carcinoma in situ: a systematic review. Supportive care in cancer. 2024 Oct 1;32(10):695.
• 木川 雄一郎【乳癌学2024(下)-最新の診断と治療-】フォローアップとトータルヘルスケア　乳癌診療におけるQOL/PRO評価 日本臨床 82(増刊7 乳癌学. 2024/09 (下)):201
• 平井 千惠, 高田 正泰【乳癌学2024(下)-最新の診断と治療-】乳癌の薬物療法　経口FU薬の進歩と乳癌治療における役割 日本臨床 82(増刊7 乳癌学. 2024/09 (下)):125
• Narusawa E, Sadeghi S, Tane K, Al-Khaifi M, Kikawa Y. Updates on the preventions and management of post-mastectomy pain syndrome beyond medical treatment: a comprehensive narrative review. Ann Palliat Med. 2024 Sep;13(5):1258-1264.
• Takahashi M, Kikawa Y, Kashiwabara K, Taira N, Iwatani T, Shimozuma K, Ohtani S, Yoshinami T, Watanabe J, Kashiwaba M, Watanabe K, Kitada M, Sakaguchi K, Tanabe Y, Aihara T, Mukai H. Eribulin versus S-1 as fi rst or second-line chemotherapy to assess health-related quality of life and overall survival in HER2-negative metastatic breast cancer (RESQ study): a noninferiority, randomised, controlled, open-label, phase 3 trial. EClinicalMedicine. 2024 Jul 16:74:102715.
• Mizusawa J, Ogawa G, Terada M, Ishiki H, Kikawa Y, Kiyota N. Statistical Analysis Methods and Reporting of Patient-Reported Outcomes in Randomized Controlled Trials for Cancer Conducted in Japan: A Systematic Review. Cureus. 2024 May; 16(5):e60804.
• Takeshita T, Iwamoto T, Niikura N, Watanabe K, Kikawa Y, Kobayashi K, Iwakuma N, Okamura T, Tada H, Ozaki S, Okuno T, Toh U, Yamamoto Y, Tsuneizumi M, Ishiguro H, Masuda N, Saji S. Identifying prognostic biomarkers for palbociclib add-on therapy in fulvestrant-resistant breast cancer using cell-free DNA sequencing. ESMO. 2024 Apr;9(4):102385.
• Yagyu T, Miki H, Kikawa Y, Kobayashi T, Sekimoto M. Appendiceal Metastasis of Breast Cancer: A Case Report and a Literature Review. Cureus. 2024 Apr 9;16(4):e57929.
• Kasahara M, Kanematsu S, Tanaka Y, Okazaki S, Watatani M. Clinical benefits of tomosynthesis-guided vacuum assisted breast biopsy: a comparison with stereotactic vacuum assisted biopsy. Breast cancer. 2024 Mar;31(2):329-334.